Acuitas Therapeutics, Inc.

We celebrate the diverse identities within the 2SLGBTQIA+ community. Canada Pride 2024 serves as a call to action, highlighting the importance of advocating for 2SLGBTQIA+ rights on a global scale. Starting today, until August 4, Vancouver will be transformed into a hub of celebration featuring VanPrideFest and the Vancouver Pride Parade. This year, Vancouver’s inaugural Human Rights Conference has been added, which will address the urgent challenges confronting the Queer community, here in Canada and globally. For more information on Canada Pride 2024, please visit: https://lnkd.in/gpkchHda. #AcuitasTherapeutics #Pride #CanadaPride2024 #Vancouver #YVR

PUBLICATION ALERT Collaboration with scientists from the Gouon-Evans Lab at the Center for Regenerative Medicine and the Weissman and Pardi Labs at University of Pennsylvania Perelman School of Medicine studying the stimulation of key regenerative pathways in transplanted PHHs using human HGF and human EGF delivered with mRNA-LNP drastically improves donor PHH engraftment as an alternative to liver transplantation and restores liver function (Nature Communications 2024). https://lnkd.in/eVrq3AgV #AcuitasTherapeutics #LipidNanoparticles #LNP #mRNA #NucleicAcids #LiverDisease

As a Major Partner, we strongly support Science World’s goal to inspire the next generation of problem solvers, world changers and nerds. In fact, we feel seen by this description – Acuitas is proudly made up of these very same types of people. We know how important the next generation of problem solvers and world changers are to the future of the world. We can’t say enough good things about our partner. https://lnkd.in/gACf8F2 #AcuitasTherapeutics #Science #STEAM #STEM #Vancouver #YVR

On Wednesday, a group of Acuitas colleagues played basketball on the court outside of our workspace during lunch. Even though some had never played before, everyone had a lot of fun and laughs. #AcuitasTherapeutics #AGreatPlaceToWork #ILoveMyJob #Vancouver #YVR #LNP #LipidNanoparticles

Working with our partners, we provide deep expertise in the entire drug development process and, enabled by our best-in-class lipid nanoparticle delivery technology, we help to accelerate their path to the clinic and the market. We offer a true partnership where collaboration is the foundation and success is shared.   You can read articles published by scientific journals on studies that we have participated in with partners here: https://lnkd.in/g57xwsc. #AcuitasTherapeutics #mRNA #LipidNanoparticles #LNP #NucleicAcidTherapeutics

Acuitas was away from the office on Friday for a day of team-building exercises on the ocean – kayaking, games and a fabulous lunch. What a great way to start the weekend, connect with our colleagues, and have fun in a beautiful place. #AcuitasTherapeutics #AGreatPlaceToWork #ILoveMyJob #Vancouver #YVR #LNP #LipidNanoparticles

The entire Acuitas team is responsible for our great company culture. It’s just one of the many reasons why we were named one of Canada’s Top Small & Medium Employers and one of BC’s Top Employers in 2024. Are you interested in working at Acuitas? You can learn about our exceptional corporate culture here: https://lnkd.in/gwPkbkC5. #AcuitasTherapeutics #mRNA #LipidNanoparticles #LNP #NucleicAcidTherapeutics #Vancouver #YVR #AGreatPlaceToWork

Congratulations to Dr. Pieter Cullis and Phil Felgner on their recent article published by Nature Reviews Drug Discovery on the 60-year evolution of lipid nanoparticles for nucleic acid delivery. Dr. Cullis is one of three co-founder Acuitas Therapeutics with Dr. Tom Madden and Dr. Michael Hope. https://lnkd.in/d-Pr2wai #AcuitasTherapeutics #LipidNanoparticles #LNP #mRNA #COVID

PUBLICATION ALERT Collaboration with scientists from the University of Pennsylvania to use HSC targeted LNP to generate a mouse model of lethal α-Thalassemia and treatment via lentiviral gene therapy (Blood 2024). https://lnkd.in/gfnGQEVa #AcuitasTherapeutics #LipidNanoparticles #LNP #mRNA #GeneTherapy

Let’s Talk Science celebrates over $556,675 in combined gifts from Acuitas Therapeutics, Inc., Accenture , NCR Foundation (NCR Corporation), Lewitt Family Foundations & the Colcleugh Leadership Program to empower youth as innovators and problem solvers. Together, we're focused on igniting a passion in STEM and preparing youth to be workforce ready in all regions of Canada! Learn more: https://bit.ly/3LisUIN #LetsTalkScience30 #STEMEducation